SCHEMBL7966617

SCHEMBL7966617

CC(C)c1cc(C=C(C#N)S(=O)(=O)c2ccc(C(F)(F)F)cc2)cc(C(C)C)c1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.45
HPGD P15428 5/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
ALDH1A1 P00352 4/20 0.44
PKM P14618 3/20 0.44
KMT2A Q03164 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
KDM4E B2RXH2 2/20 0.44
HSD17B10 Q99714 2/20 0.44
MEN1 O00255 2/20 0.44
POLB P06746 1/20 0.44
GAA P10253 1/20 0.44
ALPG P10696 1/20 0.44
ALOX15 P16050 1/20 0.44
ALOX12 P18054 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
MAPT P10636 3/20 0.37
KDR P35968 1/20 0.37
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7966616 1.00 EGFR (0.45) EGFRHPGDSMN1; SMN2ALDH1A1PKM
SCHEMBL7966614 1.00 EGFR (0.45) EGFRHPGDSMN1; SMN2ALDH1A1PKM
SCHEMBL7967172 0.88 SMN1; SMN2 (0.44) EGFRHPGDSMN1; SMN2ALDH1A1PKM
SCHEMBL7967179 0.88 SMN1; SMN2 (0.44) EGFRHPGDSMN1; SMN2ALDH1A1PKM
SCHEMBL7967176 0.88 SMN1; SMN2 (0.44) EGFRHPGDSMN1; SMN2ALDH1A1PKM
SCHEMBL7963152 0.87 PKM (0.57) EGFRHPGDSMN1; SMN2ALDH1A1PKM
SCHEMBL7963145 0.87 PKM (0.57) EGFRHPGDSMN1; SMN2ALDH1A1PKM
SCHEMBL7963148 0.87 PKM (0.57) EGFRHPGDSMN1; SMN2ALDH1A1PKM
SCHEMBL4075770 0.86 PKM (0.47) EGFRHPGDSMN1; SMN2ALDH1A1PKM
SCHEMBL4077025 0.86 PKM (0.47) EGFRHPGDSMN1; SMN2ALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6225346-B1 FOR THERAPY AND PROPHYLAXIS OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. 2001-05-01 US disclosed